Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.
Press releases published on July 22, 2025

PSB Holdings, Inc. Reports Record Quarterly Earnings of $0.89 Per Diluted Share; Net Interest Margin Improves For Fifth Consecutive Quarter
WAUSAU, Wis., July 22, 2025 (GLOBE NEWSWIRE) -- PSB Holdings, Inc. (“PSB”) (OTCQX: PSBQ), the holding company for Peoples State Bank (“Peoples”) serving Northcentral and Southeastern Wisconsin reported second quarter earnings ending June 30, 2025 up 48% …

LiveOne (NASDAQ: LVO) executive produces New Russ Album, Publishing division drives significant revenue & debuts at #1 on Billboard Indie Charts
LOS ANGELES, July 22, 2025 (GLOBE NEWSWIRE) -- LiveOne (NASDAQ: LVO), an award-winning, creator-first, music, entertainment, and technology platform, announced today that its executive producer Kiri Gerbs has played a pivotal role in the remarkable success …

LOBO EV (NASDAQ: LOBO) Unveils $3 Million Annual Revenue Opportunity with AI-Powered Senior Mobility Robot Launching October 2025
WUXI, China, July 22, 2025 (GLOBE NEWSWIRE) -- LOBO EV Technologies Ltd. (NASDAQ: LOBO) (“LOBO” or the “Company”), a leading manufacturer and innovator in electric mobility and intelligent systems, today announced a strategic partnership with the Jiangsu …

Autonomix Medical, Inc. Exercise of Warrants for $2.5 Million Gross Proceeds
THE WOODLANDS, TX, July 22, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it has entered into agreements …

ODYSIGHT.AI AND A MULTINATIONAL TECHNOLOGY GROUP SIGN STRATEGIC COLLABORATION AGREEMENT AIMED TO DEPLOY PREDICTIVE MAINTENANCE CAPABILITIES ACROSS MULTIPLE PLATFORMS
OMER, Israel, July 22, 2025 (GLOBE NEWSWIRE) -- Odysight.AI Inc. (NASDAQ: ODYS) is proud to announce a commercial collaboration agreement with a multinational technology group to deploy one or more proof-of-concepts using Odysight.AI’s systems. The initial …

VivoPower Strengthens Balance Sheet, Further Reduces Debt by US$7.5 Million
Selected lenders and suppliers have elected to take VivoPower ordinary shares in lieu of fiat currency Directors have also elected to receive VivoPower ordinary shares for certain board fees VivoPower is progressing ahead of schedule on its commitment to …

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales
HINGHAM, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced the appointment of Christina Bailey as its new Vice President of Sales. A two-time U.S. …

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients
DENVER, July 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today positive preliminary results from the SAVE Surveillance Registry which is assessing the use of the …

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025
MINNEAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the …

Brera Holdings’ Portfolio Team SS Juve Stabia Announces Key Player and Coaching Moves Ahead of 2025/26 Serie B Soccer Season
Juve Stabia’s new head coach Ignazio Abate (left) with CEO Filippo Polcino(right) Dublin, Ireland and Naples, Italy, July 22, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC (“Brera Holdings” or the “Company”) (Nasdaq: BREA), an Ireland-based international …

Interparfums Announces Fragrance License Agreement with Longchamp
NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) today announced that its subsidiary, Interparfums SA, has signed an exclusive fragrance license agreement with Longchamp, a Parisian Maison founded in 1948, through December …

Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025
CORAL GABLES, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …

RED CAT FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Red Red Cat Holdings, Inc. Investors of July 22nd Deadline and Urges Them to Inquire About Their Rights in Class Action Lawsuit
Bragar Eagel …

OSS Expands Best-In-Class High Performance Compute Portfolio with the Launch of Ponto
ESCONDIDO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS), a leader in PCIe Expansion and rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at …

Perella Weinberg to Announce Second Quarter 2025 Financial Results and to Host Conference Call on August 1, 2025
NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Perella Weinberg Partners (NASDAQ:PWP), a leading global independent advisory firm, today announced that it plans to release its financial results for the second quarter 2025 on Friday, August 1, 2025, before the …

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board
SYDNEY, July 22, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is …

BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors
CARSON CITY, Nev., July 22, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver …

LifeVantage Announces Expanded Human Clinical Study for MindBody GLP-1 System™; Findings Increase Average in Natural GLP-1 Production to Over 200%‡‡
SALT LAKE CITY, July 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced new results from its second …

Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates
SOUTH SAN FRANCISCO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that it has entered …

aTyr Pharma Announces Last Patient Visit in Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis
SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …